Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1677 1678
This examiner grants 24% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17487534 | IMMUNOCHROMATOGRAPHY | Final Rejection | FUJIFILM Corporation |
| 18528268 | METHODS TO CHARACTERIZING A FRAGMENT CRYSTALLIZABLE DOMAIN OF A BISPECIFIC ANTIBODY | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18579084 | COMPOSITIONS AND TREATMENTS FOR CORONAVIRUS INFECTIONS | Non-Final OA | Ohio State Innovation Foundation |
| 17045312 | DIAGNOSTICS OF MILD OR ADVANCED PERIODONTITIS | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 16972259 | DETECTION OF IMMUNE CHECKPOINT MOLECULES BY DEGLYCOSYLATION | Non-Final OA | Board of Regents, The University of Texas System |
| 17825867 | SOLUTION PHASE SINGLE MOLECULE CAPTURE AND ASSOCIATED TECHNIQUES | Final Rejection | Nautilus Subsidiary, Inc. |
| 17423939 | DETECTION OF CEREBROSPINAL FLUID | Non-Final OA | Gwangju Institute of Science and Technology |
| 17199926 | Rapid And Ultrasensitive Analyte Detection For Screening In Community Settings | Final Rejection | The Trustees of the University of Pennsylvania |
| 17634843 | METHODS TO DETECT MTBR TAU ISOFORMS AND USE THEREOF | Final Rejection | Washington University |
| 18001449 | SARS-COV-2 POLYPEPTIDE, ANTI-SARS-COV-2 ANTIBODIES AND USES THEREOF | Non-Final OA | Rutgers, The State University of New Jersey |
| 17150504 | METHODS OF IDENTIFYING AN INDIVIDUAL AS HAVING OR BEING AT RISK OF DEVELOPING AN AMYLOID-POSITIVE DEMENTIA BASED ON MARKER MOLECULES AND RELATED USES | Final Rejection | Roche Diagnostics Operations, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy